MEDICURE INC. (MCUJF) earnings per share
MEDICURE INC. reports in CAD; the
per-share figures below are in CAD as filed with SEC
EDGAR, not US dollars.
Annual history
Fiscal years 2017 – 2024
CAD / SHARE 10 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2024 | 2024-12-31 | -C$0.10 | 2025-04-25 |
| FY 2023 | 2023-12-31 | -C$0.09 | 2024-04-09 |
| FY 2022 | 2022-12-31 | C$0.13 | 2023-04-06 |
| FY 2021 | 2021-12-31 | -C$0.07 | 2022-04-29 |
| FY 2020 | 2020-12-31 | -C$0.64 | 2021-04-21 |
| FY 2019 | 2019-12-31 | -C$1.32 | 2020-04-16 |
| FY 2018 | 2018-12-31 | C$0.24 | 2019-04-30 |
| FY 2017 | 2017-12-31 | C$2.39 | 2018-05-15 |
| FY 2017 | 2016-12-31 | C$1.56 | 2018-05-15 |
| FY 2017 | 2015-12-31 | C$0.11 | 2018-05-15 |
Quarterly history
Fiscal years 2025
CAD / SHARE 2 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | -C$0.07 | 2025-05-21 |
| Q1 2025 | 2024-03-31 | C$0.00 | 2025-05-21 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (1 split since 2012).
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
MCUJF CIK 0001133519 Source: EDGAR filings · all facts